{
  "paper_metadata": {
    "pmid": "29593496",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the aggregation of transthyretin (TTR) in yeast models, focusing on the interaction with yeast prion proteins. It mentions a specific engineered TTR variant but does not provide detailed clinical or penetrance data for human cases."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Phe87Met, p.Leu110Met",
      "genomic_position": null,
      "clinical_significance": "Not specified",
      "patients": {
        "count": 0,
        "demographics": "",
        "phenotype": ""
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The M-TTR-GFP variant (F87M/L110M) was engineered to study aggregation in yeast. It showed increased aggregation compared to WT-TTR-GFP, especially in the presence of the yeast prion [PSI+].",
        "assays": [
          "Yeast aggregation assay",
          "Fluorescent microscopy",
          "Immunoblotting"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "Experimental evidence in yeast model",
      "source_location": "Abstract, Results section",
      "additional_notes": "The study focuses on the interaction of TTR with yeast prions, not on human clinical data.",
      "key_quotes": [
        "We established aggregation of an engineered double (F87M/L110M) mutant M-TTR-GFP in yeast.",
        "Aggregation of M-TTR-GFP was significantly enhanced in presence of [PSI+], an endogenous prion form of Sup35."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [
      "No human clinical or penetrance data provided for TTR variants."
    ],
    "notes": "The paper primarily focuses on experimental data in yeast models, with no human genetic or clinical data available."
  }
}